PURPOSE: The number of long-term survivors after hematopoietic stem-cell transplantation (HSCT) for malignant and nonmalignant disorders is increasing, and late effects are gaining importance. Osteoporosis and fractures can worsen the quality of life of HSCT survivors, but the burden of the disease is unknown. PATIENTS AND METHODS: We conducted a retrospective study of patients older than age 18 years who underwent an HSCT at The University of Texas MD Anderson Cancer Center from January 1, 1997, to December 31, 2011, and were observed until December 31, 2013, to ascertain occurrence of fractures. Cumulative incidence rates of fractures were calculated with death as a competing risk. Age- and sex-specific incidence rates per person-year of fracture were compared with those of the US general population by using estimated rates from the 1994 National Health Interview Survey and the 2004 National Hospital Discharge Survey. RESULTS: A total of 7,620 patients underwent an HSCT from 1997 to 2011 at the MD Anderson Cancer Center of whom 602 (8%) developed a fracture. Age, underlying disease, and HSCT type were significantly associated with fracture. Age- and sex-specific fracture incidence rates after HSCT were significantly greater than those of the US general population in almost all subgroups. The striking difference was an approximately eight times greater risk in females and approximately seven to nine times greater risk in males age 45 to 64 years old when compared with the National Health Interview Survey and National Hospital Discharge Survey fracture rates. CONCLUSION: The incidence of fractures is compellingly higher after HSCT.
PURPOSE: The number of long-term survivors after hematopoietic stem-cell transplantation (HSCT) for malignant and nonmalignant disorders is increasing, and late effects are gaining importance. Osteoporosis and fractures can worsen the quality of life of HSCT survivors, but the burden of the disease is unknown. PATIENTS AND METHODS: We conducted a retrospective study of patients older than age 18 years who underwent an HSCT at The University of Texas MD Anderson Cancer Center from January 1, 1997, to December 31, 2011, and were observed until December 31, 2013, to ascertain occurrence of fractures. Cumulative incidence rates of fractures were calculated with death as a competing risk. Age- and sex-specific incidence rates per person-year of fracture were compared with those of the US general population by using estimated rates from the 1994 National Health Interview Survey and the 2004 National Hospital Discharge Survey. RESULTS: A total of 7,620 patients underwent an HSCT from 1997 to 2011 at the MD Anderson Cancer Center of whom 602 (8%) developed a fracture. Age, underlying disease, and HSCT type were significantly associated with fracture. Age- and sex-specific fracture incidence rates after HSCT were significantly greater than those of the US general population in almost all subgroups. The striking difference was an approximately eight times greater risk in females and approximately seven to nine times greater risk in males age 45 to 64 years old when compared with the National Health Interview Survey and National Hospital Discharge Survey fracture rates. CONCLUSION: The incidence of fractures is compellingly higher after HSCT.
Authors: G Leidig-Bruckner; S Hosch; P Dodidou; D Ritschel; C Conradt; C Klose; G Otto; R Lange; L Theilmann; R Zimmerman; M Pritsch; R Ziegler Journal: Lancet Date: 2001-02-03 Impact factor: 79.321
Authors: R Ramsey-Goldman; J E Dunn; D D Dunlop; F P Stuart; M M Abecassis; D B Kaufman; C B Langman; M H Salinger; S M Sprague Journal: J Bone Miner Res Date: 1999-03 Impact factor: 6.741
Authors: S Yao; P L McCarthy; L M Dunford; D M Roy; K Brown; P Paplham; M Syta; D Lamonica; S Smiley; M Battiwalla; S Padmanabhan; T Hahn Journal: Bone Marrow Transplant Date: 2007-11-12 Impact factor: 5.483
Authors: A Grigg; B Butcher; B Khodr; A Bajel; M Hertzberg; S Patil; A B D'Souza; P Ganly; P Ebeling; E Wong Journal: Bone Marrow Transplant Date: 2017-06-19 Impact factor: 5.483
Authors: Huifang Lu; Richard E Champlin; Uday Popat; Xerxes Pundole; Carmelita P Escalante; Xuemei Wang; Wei Qiao; William A Murphy; Robert F Gagel Journal: Bonekey Rep Date: 2016-10-19
Authors: D L Kendler; J J Body; M L Brandi; R Broady; J Cannata-Andia; M J Cannata-Ortiz; A El Maghraoui; G Guglielmi; P Hadji; D D Pierroz; T J de Villiers; R Rizzoli; P R Ebeling Journal: Osteoporos Int Date: 2018-09-03 Impact factor: 4.507
Authors: Filip Pirsl; Lauren M Curtis; Seth M Steinberg; Sri Harsha Tella; Mašenjka Katić; Marnie Dobbin; Jennifer Hsu; Fran T Hakim; Jacqueline W Mays; Annie P Im; Dražen Pulanić; Sandra A Mitchell; Judy Baruffaldi; Licia Masuch; David C Halverson; Ronald E Gress; Julianna Barsony; Steven Z Pavletic Journal: Biol Blood Marrow Transplant Date: 2016-04-23 Impact factor: 5.742
Authors: P Anandi; N A Jain; X Tian; C O Wu; P A Pophali; E Koklanaris; S Ito; B N Savani; J Barrett; M Battiwalla Journal: Bone Marrow Transplant Date: 2016-04-04 Impact factor: 5.483
Authors: E Gielen; P Bergmann; O Bruyère; E Cavalier; P Delanaye; S Goemaere; J-M Kaufman; M Locquet; J-Y Reginster; S Rozenberg; A-M Vandenbroucke; J-J Body Journal: Calcif Tissue Int Date: 2017-03-21 Impact factor: 4.333